Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dahlia Ismail
Observed name:
Ismail, Dahlia
Institution:
Santen (France)
Observed institutions:
Santen (France),
Universitas Islam Makassar
OpenAlex ID:
A5110602157
Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease: A Multicenter Randomized Trial
2016
·
Andrea Leonardi
, Gysbert Van Setten
, et al.
·
European Journal of Ophthalmology
·
203
PDF
A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye
2017
·
Christophe Baudouin
, Francisco C. Figueiredo
, et al.
·
European Journal of Ophthalmology
·
116
A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis
2018
·
Andrea Leonardi
, Serge Doan
, et al.
·
Ophthalmology
·
99
PDF
One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease
2017
·
Christophe Baudouin
, Maite Sainz de la Maza
, et al.
·
European Journal of Ophthalmology
·
94
PDF
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies
2018
·
Andrea Leonardi
, Elisabeth M Messmer
, et al.
·
British Journal of Ophthalmology
·
71
PDF
Correlation Between the Inflammatory Marker HLA-DR and Signs and Symptoms in Moderate to Severe Dry Eye Disease
2017
·
Françoise Brignole-Baudouin
, Luisa Riancho
, et al.
·
Investigative Ophthalmology & Visual Science
·
56
Efficacy and Safety of a Cationic Emulsion in the Treatment of Moderate to Severe Dry Eye Disease: A Randomized Controlled Study
2016
·
Pierre-Yves Robert
, Béatrice Cochener
, et al.
·
European Journal of Ophthalmology
·
49
PDF
Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease
2020
·
Philippe Daull
, Mourad Amrane
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
46
PDF
Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis
2019
·
Dominique Bremond-Gignac
, Serge Doan
, et al.
·
American Journal of Ophthalmology
·
46
PDF
Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study
2018
·
Marc Labetoulle
, Andrea Leonardi
, et al.
·
Clinical Therapeutics
·
34
PDF
Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program
2018
·
Pierre-Jean Pisella
, Marc Labetoulle
, et al.
·
Clinical ophthalmology
·
32
PDF
Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials
2022
·
Andrea Leonardi
, Serge Doan
, et al.
·
Eye
·
15
PDF
Poor Correlation Between Dry Eye Disease (DED) Signs and Symptoms in a Phase III Randomized Clinical Trial
2011
·
Michael A. Lemp
, Christopher Baudouin
, et al.
·
Investigative Ophthalmology & Visual Science
·
12
NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal Keratoconjunctivitis
2023
·
Andrea Leonardi
, Pierre-Jean Pisella
, et al.
·
Clinical Therapeutics
·
7
PDF
Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease
2024
·
Marc Labetoulle
, Gerhard Garhöfer
, et al.
·
Acta Ophthalmologica
·
4
PDF
Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study
2024
·
Jason Bacharach
, Eugene B. McLaurin
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
3
Safety and Tolerability of Topical Cyclosporine A Cationic Emulsion in Patients With Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Pooled Results of the NOVATIVE and VEKTIS Trials
2019
·
Dominique Brémond‐Gignac
, Pasquale Aragona
, et al.
·
Investigative Ophthalmology & Visual Science
·
2
Topical Ciclosporin A 1 mg/mL Cationic Emulsion in the Treatment of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study
2017
·
Andrea Leonardi
, Serge Doan
, et al.
·
Investigative Ophthalmology & Visual Science
·
2
Author's Reply to: “Concerns Over: Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease”
2017
·
Andrea Leonardi
, Gysbert Van Setten
, et al.
·
European Journal of Ophthalmology
·
1
Pooling of two randomized Phase III clinical trials of ciclosporin 1 mg/mL cationic emulsion (CsA CE) as a treatment for severe keratitis in patients with dry eye disease (DED)
2016
·
Elisabeth M. Messmer
, Andrea Leonardi
, et al.
·
Investigative Ophthalmology & Visual Science
·
1
The Influence of Seasonality and Subtype in Vernal Keratoconjunctivitis (VKC) Patients in a Randomized Clinical Trial Investigating NOVA22007, a preservative-free cyclosporine cationic emulsion
2012
·
Mourad Amrane
, Andrea Leonardi
, et al.
·
Investigative Ophthalmology & Visual Science
·
1
The FAST Study: Examining Quality of Vision Outcomes in Dry Eye Disease Patients with Severe Keratitis Treated with the Ciclosporin A Cationic Emulsion
2026
·
Pierre-Jean Pisella
, Amrane Mourad
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
Peningkatan Kemampuan Kognitif Anak Kelompok B Melalui Metode Proyek
2025
·
Ismail, Dahlia
, Mulyadi, Mulyadi
, et al.
·
Ihya Ulum Early Childhood Education Journal
PDF
Topical Cyclosporine A 1 mg/mL Cationic Emulsion Yields Improvements in Signs of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study
2018
·
Serge Doan
, Andrea Leonardi
, et al.
·
Investigative Ophthalmology & Visual Science
Safety and efficacy of ciclosporin 1 mg/mL cationic emulsion (CsA CE) over 12 months in patients with severe dry eye disease (DED) in the SANSIKA Phase III trial
2016
·
G.‐B. van Setten
, Francisco C. Figueiredo
, et al.
·
Investigative Ophthalmology & Visual Science
Show more works
View as search
Works count:
29
Citation count:
895
H-index:
12
I10-index:
13
Year
Topic
Type